3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
NIH
1
Study Type
Observational
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Prostatic Neoplasms
18
Neoplasms
9
Colonic Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Breast Neoplasms
6
Uterine Cervical Neoplasms
4
Colorectal Neoplasms
4
Uterine Cervical Dysplasia
3
Urinary Bladder Neoplasms
3
Mouth Neoplasms
3
Esophageal Neoplasms
3
Carcinoma, Hepatocellular
3
Thyroid Nodule
2
Thyroid Neoplasms
2
Thrombocythemia, Essential
2
Testicular Neoplasms
2
Rectal Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Polycythemia Vera
2
Oropharyngeal Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Liver Neoplasms
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia
2
Hodgkin Disease
2
Glioma
2
Gallbladder Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Basal Cell
2
Interventions
Carboplatin
23
Etoposide
19
Vincristine
16
Melphalan
13
Filgrastim
13
Topotecan
10
Granulocyte Colony-Stimulating Factor
9
Cyclophosphamide
8
Thiotepa
7
Cryotherapy
7
Peripheral Blood Stem Cell Transplantation
4
Mesna
4
Drug Therapy
4
Doxorubicin
3
Busulfan
3
Brachytherapy
3
Temozolomide
2
Radiotherapy
2
Platinum Compounds
2
Magnetic Resonance Imaging
2
Ifosfamide
2
Eye Enucleation
2
Cisplatin
2
Blood Specimen Collection
2
trioctyl phosphine oxide
1
sargramostim
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
omburtamab I-131
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Retinoblastoma
×
Watchful Waiting
×
Clear all
NCT04425434
2026-03-02
GFARB12019
French Africa Pediatric Oncology Group
Recruiting
3,000 enrolled